Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Merli

Showing results (71-80 of 216) with videos related to

Pageof 22
Sort By:
Journal of Clinical Medicine|January 21, 2022
Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic ShuntGiulia Manguso, Anthony Vignone, Manuela Merli, et al.
Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia|March 16, 2006
GFAP expression in the liver as an early marker of stellate cells activationSergio Morini, Simone Carotti, Guido Carpino, et al.
Alimentary Pharmacology & Therapeutics|August 8, 2025
Letter on 'Post-TIPS Overt Hepatic Encephalopathy Increases Long-Term but Not Short-Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large-Scale, Multicentre Real-World'Silvia Nardelli, Francesco Vizzutti, Filippo Schepis, et al.
Metabolic Brain Disease|February 27, 2003
Effect of blood ammonia elevation following oral glutamine load on the psychometric performance of cirrhotic patientsAndrea Masini, Cesare Efrati, Manuela Merli, et al.
World Journal of Gastroenterology|December 11, 2014
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosisValerio Giannelli, Vincenza Di Gregorio, Valerio Iebba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2016
Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt PlacementSilvia Nardelli, Barbara Lattanzi, Sabrina Torrisi, et al.
Nutrients|August 10, 2021
The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot StudyBarbara Lattanzi, Angelo Bruni, Simone Di Cola, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 20, 2020
ESPEN practical guideline: Clinical nutrition in liver diseaseStephan C Bischoff, William Bernal, Srinivasan Dasarathy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 13, 2018
Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosisStefania Gioia, Silvia Nardelli, Chiara Pasquale, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 5, 2019
ESPEN guideline on clinical nutrition in liver diseaseMathias Plauth, William Bernal, Srinivasan Dasarathy, et al.
Pageof 22

Showing results (71-80 of 216) with videos related to

Sort By:
Pageof 22
Journal of Clinical Medicine|January 21, 2022
Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic ShuntGiulia Manguso, Anthony Vignone, Manuela Merli, et al.
Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia|March 16, 2006
GFAP expression in the liver as an early marker of stellate cells activationSergio Morini, Simone Carotti, Guido Carpino, et al.
Alimentary Pharmacology & Therapeutics|August 8, 2025
Letter on 'Post-TIPS Overt Hepatic Encephalopathy Increases Long-Term but Not Short-Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large-Scale, Multicentre Real-World'Silvia Nardelli, Francesco Vizzutti, Filippo Schepis, et al.
Metabolic Brain Disease|February 27, 2003
Effect of blood ammonia elevation following oral glutamine load on the psychometric performance of cirrhotic patientsAndrea Masini, Cesare Efrati, Manuela Merli, et al.
World Journal of Gastroenterology|December 11, 2014
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosisValerio Giannelli, Vincenza Di Gregorio, Valerio Iebba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2016
Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt PlacementSilvia Nardelli, Barbara Lattanzi, Sabrina Torrisi, et al.
Nutrients|August 10, 2021
The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot StudyBarbara Lattanzi, Angelo Bruni, Simone Di Cola, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 20, 2020
ESPEN practical guideline: Clinical nutrition in liver diseaseStephan C Bischoff, William Bernal, Srinivasan Dasarathy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 13, 2018
Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosisStefania Gioia, Silvia Nardelli, Chiara Pasquale, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 5, 2019
ESPEN guideline on clinical nutrition in liver diseaseMathias Plauth, William Bernal, Srinivasan Dasarathy, et al.
Pageof 22